Pharma Partnerships: Amplitude Therapeutics teamed with Eli Lilly on trans-amplifying RNA vaccines, while Chai Discovery is letting Bristol Myers Squibb use its AI antibody design tools—another sign pharma is leaning hard into platform deals. Regulatory & Antitrust: Bio-Techne withdrew and refiled its $11.3B Merck merger intent, giving the FTC more time to review competition concerns. Clinical Innovation: Stamford Health became the first U.S. hospital to treat chronic low back pain with FUSMobile’s Neurolyser XR focused ultrasound system, and TriStar Greenview upgraded its cardiac cath lab with new image-guided therapy tech. Cancer Care & Diagnostics: Research links higher county medical debt to later-stage cancer diagnosis and worse survival, while conference updates highlight stereotactic brain metastases expansion and the need to retest HER2/neu at recurrence in gynecologic cancers. Public Health & Food Safety: U.S. officials are investigating a multistate E. coli and salmonella outbreak tied to alfalfa sprouts from Everything Sprouts, with CDC reporting 55 cases and four hospitalizations. Healthcare Access & Costs: A new Aon forecast projects employer healthcare costs rising 9.5% in 2027, and rural health experts warned of ongoing hospital closures and physician shortages. Digital Health Oversight: The FDA shared best practices for using wearables and other digital health tools in clinical studies, stressing validation and patient-relevant outcomes. Industry Watch: Cytek won most of its patent case against Beckman Coulter, while KPJ Healthcare’s MD announced a leadership change effective Sept. 1.